RT Journal Article
SR Electronic
T1 Persistent heterogeneity not short-term overdispersion determines herd immunity to COVID-19
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.07.26.20162420
DO 10.1101/2020.07.26.20162420
A1 Alexei V. Tkachenko
A1 Sergei Maslov
A1 Ahmed Elbanna
A1 George N. Wong
A1 Zachary J. Weiner
A1 Nigel Goldenfeld
YR 2020
UL http://medrxiv.org/content/early/2020/08/11/2020.07.26.20162420.abstract
AB It has become increasingly clear that the COVID-19 epidemic is characterized by overdispersion whereby the majority of the transmission is driven by a minority of infected individuals. Such a strong departure from the homogeneity assumptions of the traditional well-mixed compartment model is usually hypothesized to be the result of short-term super-spreader events, such as an individual’s extreme rate of virus shedding at the peak of infectivity while attending a large gathering without appropriate mitigation. However, we demonstrate that the spread of epidemics is primarily sensitive to longterm, or persistent heterogeneity of individual susceptibility or infectivity. We demonstrate how to incorporate this heterogeneity into a wide class of epidemiological models, and derive a non-linear dependence of the effective reproduction number Re on the susceptible population fraction S. Persistent heterogeneity has three important consequences compared to the effects of short-term overdispersion: (1) It results in a major modification of the early epidemic dynamics; (2) It significantly suppresses the herd immunity threshold; (3) It also significantly reduces the final size of the epidemic. We estimate social and biological contributions to persistent heterogeneity using data on real-life face-to-face contact networks and age variation of the incidence rate during the COVID-19 epidemic. In addition, empirical data from the COVID-19 epidemic in New York City (NYC) and Chicago, as well as 50 US states provide a consistent characterization of the level of heterogeneity. Our estimates suggest that the hardest-hit areas, such as NYC, are close to the heterogeneity-modified herd immunity threshold following the first wave of the epidemic. However, this type of immunity is fragile as it wanes over time if the pattern of social interactions changes substantially.Significance Statement This study demonstrates how a wide class of epidemiological models can be adapted for applications to heterogeneous populations in the context of the COVID-19 epidemic. It is shown that a persistent heterogeneity, rather than bursty short-term variations in infection transmission is responsible for self-limiting epidemic dynamics. Compact generalizations of the classical results for the herd immunity threshold and the final size of an epidemic are derived. The degree of persistent heterogeneity is estimated from data on real-life face-to-face contact networks, and on age variation of susceptibility to COVID-19. The estimate is further supported by the analysis of the empirical data from the epidemic in NYC and Chicago, as well as in 50 US states. The results suggest that by the end of the first wave of the epidemic, the hardest-hit areas, such as NYC, have been close to the heterogeneity-modified herd immunity, thereby limiting their vulnerability to a potential second wave of the epidemic.Competing Interest StatementThe authors have declared no competing interest.Funding StatementOur calculations would have been impossible without the data kindly provided by the Illinois Department of Public Health through a Data Use Agreement with Civis Analytics. This work was supported by the University of Illinois System Office, the Office of the Vice-Chancellor for Research and Innovation, the Grainger College of Engineering, and the Department of Physics at the University of Illinois at Urbana-Champaign. Z.J.W. is supported in part by the United States Department of Energy Computational Science Graduate Fellowship, provided under Award No. DE-FG02-97ER25308. This work made use of the Illinois Campus Cluster, a computing resource that is operated by the Illinois Campus Cluster Program (ICCP) in conjunction with the National Center for Supercomputing Applications (NCSA) and which is supported by funds from the University of Illinois at Urbana-Champaign. This research was partially done at, and used resources of the Center for Functional Nanomaterials, which is a U.S. DOE Office of Science Facility, at Brookhaven National Laboratory under Contract No.~DE-SC0012704.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This manuscript does not involve research on human subjects. The public data used in this study contains no identifiable private information.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe manuscript uses data provided by the Illinois Department of Public Health through a Data Use Agreement with Civis Analytics. The source code for the model is freely available online at https://github.com/uiuc-covid19-modeling/pydemic https://github.com/uiuc-covid19-modeling/pydemic